TABLE 4.
Overall Patient Survival |
Patient Survival Beyond 90 Days |
|||
---|---|---|---|---|
Predictor Variable | HR (95% CI) | P Value | HR (95% CI) | P Value |
LDLT ≤20 vs. DDLT† | 2.66 (1.42, 4.50) | 0.002 | 2.56 (1.25, 5.23) | 0.010 |
LDLT >20 vs. DDLT† | 1.34 (0.67, 2.69) | 0.404 | 1.37 (0.63, 2.96) | 0.428 |
Recipient age (per 10 years) | 1.37 (0.99, 1.91) | 0.058 | 1.18 (0.81, 1.71) | 0.387 |
Pre-LT HCC | 2.24 (1.23, 4.06) | 0.008 | 2.30 (1.19, 4.46) | 0.013 |
Laboratory MELD at LT (per 5 points) | 1.30 (1.09, 1.55) | 0.003 | 1.27 (1.04, 1.55) | 0.021 |
Tacrolimus at baseline | 0.64 (0.37, 1.10) | 0.108 | 0.76 (0.40, 1.44) | 0.399 |
Abbreviation: CI, confidence interval.
Variables tested but not significant (P > 0.10) in the multivariable Cox regression model: donor age, cold ischemia time, rejection requiring antibody (time-varying covariate), biliary complications (time-varying covariate), and antiviral treatment (time-varying covariate).
LDLT ≤20 are those LDLTs performed among the first 20 at a given center. LDLT >20 are those LDLTs performed after at least 20 LDLTs had been performed at the given center.